Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...

After the 20th week of pregnancy, either new-onset high blood pressure or worsening of existing high blood pressure accompanied by protein in the urine is defined as preeclampsia. Before 20 weeks ...

Germany-based tech company Merck has opened a new spin-on-dielectric (SOD) application centre in Anseong, South Korea. It has invested $10m (€9m) to construct the new lab. SOD is a material ...

Merck Research Laboratories. "These approvals underscore the continued expansion of the use of KEYTRUDA in diverse patient populations and treatment settings with utility of KEYTRUDA ranging from ...

Merck & Co – known as MSD outside the US and Canada – and Exelixis have entered into a clinical development collaboration to evaluate new combination treatments for head and neck cancer and renal cell ...

Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for ...

Merck's diversified pipeline includes promising oncology candidates and a new pneumococcal vaccine, but lacks a ready-made Keytruda replacement. Investors should monitor R&D updates closely ...

Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm ...

Despite Merck & Co. homing in on approval for its infant ... there isn’t a supply crunch repeat in 2024, recently adding a new filling line and shipping doses of the antibody early to get ...